Bicocca Open Archive

Logo unimib boa
PAGANI, LISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.405
EU - Europa 2.080
NA - Nord America 1.810
SA - Sud America 335
AF - Africa 40
OC - Oceania 11
Totale 6.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.730
IT - Italia 852
SG - Singapore 765
VN - Vietnam 548
CN - Cina 498
RU - Federazione Russa 326
HK - Hong Kong 303
BR - Brasile 282
DE - Germania 271
IE - Irlanda 150
SE - Svezia 104
GB - Regno Unito 85
FR - Francia 72
KR - Corea 65
ID - Indonesia 50
NL - Olanda 50
IN - India 46
CA - Canada 43
FI - Finlandia 40
AT - Austria 34
JP - Giappone 25
ZA - Sudafrica 25
ES - Italia 23
MX - Messico 23
AR - Argentina 19
PL - Polonia 17
TR - Turchia 16
BD - Bangladesh 15
EC - Ecuador 13
SA - Arabia Saudita 13
AU - Australia 11
TW - Taiwan 10
BE - Belgio 9
IR - Iran 9
LT - Lituania 9
IQ - Iraq 8
UZ - Uzbekistan 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
CO - Colombia 6
VE - Venezuela 6
UA - Ucraina 5
PH - Filippine 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
EG - Egitto 3
IL - Israele 3
MA - Marocco 3
PK - Pakistan 3
PT - Portogallo 3
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PA - Panama 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 6.681
Salva come PNG Salva come JPEG
Città #
Singapore 500
Ashburn 353
Milan 303
Hong Kong 301
Ho Chi Minh City 186
Dallas 165
Frankfurt am Main 159
Hanoi 149
Dublin 148
Hefei 148
New York 95
Los Angeles 87
Ann Arbor 85
Chandler 85
Santa Clara 83
Beijing 63
Seoul 58
Munich 50
Shanghai 42
Jakarta 35
São Paulo 35
Buffalo 30
Moscow 29
Chicago 27
Kent 27
Nuremberg 26
Florence 24
Da Nang 20
Rome 20
Brooklyn 19
Denver 19
London 19
Turku 19
Boston 17
Tokyo 17
Haiphong 16
Madison 16
Helsinki 15
Johannesburg 15
Montreal 15
The Dalles 15
Genoa 14
Hải Dương 14
Cinisello Balsamo 13
Ha Long 13
Ripalta Cremasca 13
Vienna 13
Can Tho 12
Naples 12
Orem 12
Poplar 12
Seregno 12
Toronto 12
Amsterdam 11
Biên Hòa 11
Chennai 11
Como 11
Romola 11
Stockholm 11
Warsaw 11
Bergamo 10
Monza 10
Ninh Bình 10
Quận Bình Thạnh 10
Brussels 9
Carate Brianza 9
Melzo 9
Mexico City 9
Phoenix 9
Pune 9
Sesto San Giovanni 9
Ankara 8
Cagliari 8
Düsseldorf 8
Princeton 8
Rio de Janeiro 8
Riyadh 8
Tashkent 8
Terni 8
Vercelli 8
Atlanta 7
Caronno Pertusella 7
Coventry 7
Minamikasugaoka 7
Paris 7
Segrate 7
Thái Nguyên 7
Turin 7
Bắc Ninh 6
Cape Town 6
Guayaquil 6
Hangzhou 6
Kelty 6
Lauterbourg 6
Messina 6
Padova 6
Redondo Beach 6
San Francisco 6
Tehran 6
Vũng Tàu 6
Totale 4.067
Salva come PNG Salva come JPEG
Nome #
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 489
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 293
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 291
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 269
A molecular imaging approach to individuate tumour infiltrating lymphocytes 244
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 237
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 233
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 223
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 220
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 219
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 218
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 209
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 206
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 202
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 199
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 195
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 193
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 188
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 187
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 187
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 185
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 180
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 172
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 166
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 164
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 137
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids 129
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 126
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 124
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 118
Proteomic and glycoproteomic approaches based on nLC-ESI MS/MS for exploring cancer matrisome: explorative study 118
Tailored proteomic approaches based on nano-Liquid Chromatography-Mass Spectrometry to address biomedical challenging issues 118
Proteomic characterization and comparison of human platelet lysates for a standardized and high quality production 106
Proteomic monitoring by label-free nLC-MS/MS of human platelet lysates for a standardized and optimized production 97
Deep proteome investigation in clinical studies: from the method development to its application 80
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 74
Revisiting Thyroglobulin Measurement: Current Methods and Future Perspectives Using Dried Blood Spot Sampling for Enhanced Clinical Practice 9
Totale 6.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 8 30 21 19 0 9 7 7 24 30
2022/2023596 68 84 61 87 38 74 23 35 37 19 30 40
2023/2024733 19 22 27 84 64 188 114 39 50 16 35 75
2024/20252.259 72 169 142 111 218 106 158 72 234 387 215 375
2025/20263.062 958 396 492 699 457 60 0 0 0 0 0 0
Totale 6.805